Overview

Opioid Antagonism in Individuals Ascertained Through the Partners HealthCare Biobank

Status:
Enrolling by invitation
Trial end date:
2025-02-28
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Stephanie B. Seminara, MD
Treatments:
Naloxone